empty
ABBV
AbbVie Inc
214.39 41.33 (0.24%)
07 Mar 2025 22:59
Buy
214.39
Sell
214.18
100%
Traders' feedback
0%
Closing
213.79
Maximum price
173.82
One week high
215.33
52-week high
206.18
Opening
213.77
Minimum price
171.19
One week low
206.54
52-week low
153.48
About
Overview
Technical
Instrument specification (#ABBV)
Insta.Standard
Insta.Eurica
Buy
214.39
Sell
214.18
Commission
0.1%
Leverage
1:10
Lot
100 stocks
Spread
21
Buy swap
-7% (0%*)
Sell swap
3%; 0%*
Minimum trade size
0.01 Lot
Short position
Available
Trading time
16:30-23:00 (UTC+3) Mo-Fr
P/E Ratio
0.00
Debt-to-equity ratio
-
P/B Ratio
-
ROE
-
EPS
-
Forward Dividend & Yield
0.00(0.00%)
Beta
-
Net Profit Margin
-
#ABBV(AbbVie Inc). Forex quotes and online charts.

AbbVie Inc. About company AbbVie Inc. is an American biopharmaceutical company. Read more...

AbbVie Inc. About company

AbbVie Inc. is an American biopharmaceutical company. It was founded in 2013 after Abbott Laboratories split into two separate companies. In the same year, AbbVie Inc. was listed on the New York Stock Exchange as a separate company under the ABBV ticker.

The company’s mission is to develop and deliver innovative medicines that solve serious health issues. Since its foundation, the company has invested more than $50 billion in the research and development of world-class medicines.

Nowadays, it employs more than 50,000 people worldwide. Its production facilities and research centers are located in 20 countries.

In 2021, the company's total revenue amounted to $56.2 billion. AbbVie's GAAP net profit for the 6 months of 2022 totaled $5.42 billion, an increase of 25.4% compared to $4.32 billion in the previous year. Its revenue jumped by 4.3% to $28.12 billion against $26.97 billion a year earlier.

AbbVie Inc. shares and factors impacting their price

Currently, the company's shares are traded between $140-145, which is four times higher since its IPO 10 years ago. Over the past year, the stock price has fluctuated in the range of $106.86 -$175.91.

Its shares are growing slowly but surely without sharp price swings. Thus, the purchase of AbbVie Inc. stock can be deemed a good long-term investment.

AbbVie allocates 45-50% of available funds annually to pay dividends to its shareholders. The amount of dividends is quite decent. For this reason, the company is classified as a dividend aristocrat.

Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.